Catherine Frenette is a Gastroenterology physician affiliated with Gilead Sciences. OpenAlex indexes 149 publications with 3,711 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10666 N Torrey Pines Rd
N200
La Jolla, CA 920371027
Telephone
858-554-4310Provider last certified this registry record 18 Aug 2023.
Clinical trials
- Optimization for Regorafenib in HCC
Sponsor: SC Liver Research Consortium, LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AIMMUNE THERAPEUTICS, INC.Program year20241 payment
- Gilead Sciences, Inc.Program year20231 payment
- Exelixis Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
39.9%Proton pump inhibitor13.2%Pantoprazole Sodium70%Omeprazole30%Part D<11 patientsBile Acid11%Ursodiol100%Part D≥18 patients+ 3 more classes in this area
Cancer & immunology
25.7%Calcineurin inhibitor23.6%Tacrolimus90%Cyclosporine Modified10%Part D<11 patientsKinase inhibitor2.1%Sirolimus100%Part D<11 patientsCardiovascular
20.3%Aldosterone antagonist (MRA)5.4%Spironolactone100%Part D≥13 patientsLoop diuretic3.8%Furosemide100%Part D≥11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
John McHutchison, MD
Gilead Sciences
Jared Baeten, MD
Gilead Sciences
Joel Gallant, MD, MPH
Gilead Sciences
Wendy Verret
Gilead Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”